ICH Q10 - Pharmaceutical Quality System ICH-Q10-Section1-Enablers-KnowledgeMgmt-QRM-FoundationICH-Q8-Q9: ICH Q10 Section 1 - PQS Enablers + Knowledge Management + Quality Risk Management (ICH Q9 Foundation)
Section 1.6 introduces two key Pharmaceutical Quality System (PQS) Enablers - Knowledge Management and Quality Risk Management. Section 4.1 Knowledge Management: systematic approach to acquiring + analysing + storing + disseminating information related to products + manufacturing processes + components; sources include prior knowledge from public domain + new product development + technology transfer + process validation + manufacturing experience + complaints + adverse events + product quality reviews + literature; knowledge management enables science-based + risk-based decisions throughout product lifecycle; encompasses tacit (Subject Matter Expert SME experience) and explicit (documents + databases + systems) knowledge. Section 4.2 Quality Risk Management (QRM) per ICH Q9: integrated approach across the product lifecycle; risk identification + risk analysis + risk evaluation + risk control + risk communication + risk review; risk-based decision-making for: product development + manufacturing + technology transfer + commercial scale-up + change management + investigation + CAPA + audit + supplier qualification + facility design + utilities. Q9(R1) released 2023 enhanced QRM with: subjectivity in risk assessment + risk-based formality + clarity on hazard identification + improved guidance on tools (FMEA + HACCP + HAZOP + Bow-Tie). PQS Enablers underpin all Section 2 (Management Responsibility) + Section 3 (Continual Improvement) + 4 Lifecycle Stages activities. Coordinates with ICH Q9 (R1) + Q8 (Design Space + Control Strategy) + Q12 (Established Conditions) + GAMP 5 + FDA Process Validation Guidance + EMA + PMDA + ASTM E2500 (Specification + Design + Verification of Pharmaceutical Manufacturing Systems and Equipment). ICH Q10 Section 1 + Enablers + Knowledge Mgmt + QRM applies.
Maintained by Gerard Blokdyk·Verified against the published standard ·Control text last updated
What else in your programme already covers this
This control maps to 120 controls across 65 other frameworks. If you already hold one of them, the evidence you collected for it is the starting point here rather than new work.
JP-AIG-Safety-Validation-Testing-Robustness-AISI-AI-Safety-Institute-Pre-Deployment-Evaluation-Red-Teaming Japan AI Guidelines Safety + Validation + Testing + Robustness + AISI AI Safety Institute (14 Feb 2024) + Pre-Deployment Evaluation + Red Teaming + Capability Evaluations + AI Incident Database + Safe Deployment + AI Safety Reports
NIST-CSF-GV.RM-03 Cybersecurity risk management activities and outcomes are included in enterprise risk management processes
NIST-CSF-GV.RM-04 Strategic direction that describes appropriate risk response options is established and communicated
NIST-CSF-GV.SC-01 A cybersecurity supply chain risk management program, strategy, objectives, policies, and processes are established and agreed to by organizational stakeholders